[Botulinum toxin type A in children: evaluation of indications with a review of the literature]
- PMID: 12928142
- DOI: 10.1016/s0168-6054(03)00107-7
[Botulinum toxin type A in children: evaluation of indications with a review of the literature]
Abstract
Introduction: The aim of this study is to review the literature to indications of botulinum toxin type A in children.
Method: We review the international literature from 1990 to 2002 by querying the Pubmed database with the keywords "children" and "botulinum toxin".
Results: Two hundred and forty-eight articles are retrieved. We selected the most relevant 64 articles among them. Several questions remain pending: which optimal dose, which periodicity for injections, which optimal age to prolong efficiency? The main criteria to estimate efficiency is functional ability improvement. No significant side effects are noted. The main use of botulinum toxin is the management of the spastic lower limb in cerebral palsy.
Discussion: This review of the literature makes it possible to specify the interests and the operational limits of botulinum toxin in the child. Its effectiveness with the upper limb is not proven. The other indications remain to be studied in a more precise way.
Conclusion: This review shows many studies give the indications of botulinum toxin in children. The main indication is the lower limb spaticity in cerebral palsy. New prospective and double-blind studies should be performed with larger samples.
Similar articles
-
Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.Eur J Paediatr Neurol. 2016 Jul;20(4):532-7. doi: 10.1016/j.ejpn.2016.04.008. Epub 2016 Apr 22. Eur J Paediatr Neurol. 2016. PMID: 27177451 Clinical Trial.
-
Botulinum Toxin in Children with Cerebral Palsy: An Update.Neuropediatrics. 2020 Feb;51(1):1-5. doi: 10.1055/s-0039-1694988. Epub 2019 Sep 4. Neuropediatrics. 2020. PMID: 31486052 Review.
-
IncobotulinumtoxinA Efficacy/Safety in Upper-Limb Spasticity in Pediatric Cerebral Palsy: Randomized Controlled Trial.Pediatr Neurol. 2021 Oct;123:10-20. doi: 10.1016/j.pediatrneurol.2021.05.014. Epub 2021 May 21. Pediatr Neurol. 2021. PMID: 34339951 Clinical Trial.
-
Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.Yonsei Med J. 2016 Mar;57(2):496-504. doi: 10.3349/ymj.2016.57.2.496. Yonsei Med J. 2016. PMID: 26847306 Free PMC article.
-
Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials.JBJS Rev. 2020 Mar;8(3):e0119. doi: 10.2106/JBJS.RVW.19.00119. JBJS Rev. 2020. PMID: 32224633 Free PMC article.
Cited by
-
Cerebral palsy of the child in rehabilitation environment: epidemiologic and clinical profile and therapeutic modalities.Tunis Med. 2023 Jul 5;101(7):642-647. Tunis Med. 2023. PMID: 38445427 Free PMC article. English.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical